key: cord-0750301-sdcjnxb7
authors: Lu, Xiaoting; Cui, Zhenhai; Ma, Xiang; Pan, Feng; Li, Lingli; Wang, Jiazheng; Sun, Peng; Li, Huiqing; Yang, Lian; Liang, Bo
title: The association of obesity with the progression and outcome of COVID‐19: The insight from an artificial‐intelligence‐based imaging quantitative analysis on computed tomography
date: 2022-02-01
journal: Diabetes Metab Res Rev
DOI: 10.1002/dmrr.3519
sha: feaa018a8c817eff518f73bfcc22d1fa8b145faf
doc_id: 750301
cord_uid: sdcjnxb7

AIMS: To explore the association of obesity with the progression and outcome of coronavirus disease 2019 (COVID‐19) at the acute period and 5‐month follow‐up from the perspectives of computed tomography (CT) imaging with artificial intelligence (AI)‐based quantitative evaluation, which may help to predict the risk of obese COVID‐19 patients progressing to severe and critical disease. MATERIALS AND METHODS: This retrospective cohort enrolled 213 hospitalized COVID‐19 patients. Patients were classified into three groups according to their body mass index (BMI): normal weight (from 18.5 to <24 kg/m(2)), overweight (from 24 to <28 kg/m(2)) and obesity (≥28 kg/m(2)). RESULTS: Compared with normal‐weight patients, patients with higher BMI were associated with more lung involvements in lung CT examination (lung lesions volume [cm(3)], normal weight vs. overweight vs. obesity; 175.5[34.0–414.9] vs. 261.7[73.3–576.2] vs. 395.8[101.6–1135.6]; p = 0.002), and were more inclined to deterioration at the acute period. At the 5‐month follow‐up, the lung residual lesion was more serious (residual total lung lesions volume [cm(3)], normal weight vs. overweight vs. obesity; 4.8[0.0–27.4] vs. 10.7[0.0–55.5] vs. 30.1[9.5–91.1]; p = 0.015), and the absorption rates were lower for higher BMI patients (absorption rates of total lung lesions volume [%], normal weight vs. overweight vs. obesity; 99.6[94.0–100.0] vs. 98.9[85.2–100.0] vs. 88.5[66.5–95.2]; p = 0.013). The clinical‐plus‐AI parameter model was superior to the clinical‐only parameter model in the prediction of disease deterioration (areas under the ROC curve, 0.884 vs. 0.794, p < 0.05). CONCLUSIONS: Obesity was associated with severe pneumonia lesions on CT and adverse clinical outcomes. The AI‐based model with combinational use of clinical and CT parameters had incremental prognostic value over the clinical parameters alone.

As of 27 April 2021, the Coronavirus Disease 19 brought over 148,329,348 confirmed cases and over 3, 128, 962 deaths globally since the start of the pandemic, according to the situation report of the World Health Organization (WHO). 1 Many studies reported that obesity was associated with a worse clinical prognosis including respiratory failure, intensive care unit (ICU) admission and death in hospitalized COVID-19 patients, [2] [3] [4] [5] and some studies indicated that obese patients showed more severe pneumonia lesions on computed tomography (CT) chest imaging. 6 For example, the CORONADO study involving 1317 participants from 53

French centres found that the body mass index (BMI) was positively and independently associated with a higher risk of tracheal intubation (for mechanical ventilation) and/or death within 7 days of admission. 7 In another study that included 5279 COVID-19 patients from New York City, USA, Petrilli et al. reported that patients with a BMI >40 kg/m 2 were associated with a higher risk of critical illness (odds ratio [OR] 1.5) and hospital admission (OR 2.5). 8 While BMI does not discriminate between fat and lean body mass and poorly reflects fat distribution, more precisely, increased visceral adipose tissue (VAT) on CT was reported associated with critical illness, and visceral fat accumulation was a better predictor of the severity of COVID-19 outcome. [9] [10] [11] In a CT imaging study of obese patients, Luo et al. reported that obese COVID-19 patients showed more severe pneumonia lesions on CT, using artificial intelligence (AI)-supported quantification analysis during hospitalization. 6 However, the comprehensive assessment of the relationship between BMI, VAT, AI-supported quantification analysis and the risk of severe COVID- 19 were not reported to the authors' knowledge as so far; this current work compensated for the deficiency, and also, this work observed the absorption of lung lesion on CT at the 5-month followup which was not present in the above-mentioned studies and explored the predictors of baseline clinical parameters, BMI, VAT and visceral fat deltas 5-month baseline that may impact the CT appearance of lung lesions on the follow-up period.

Hospital, Tongji Medical College, Huazhong University of Science and Technology, and following the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Informed consent was waived for this retrospective study.

This retrospective study enrolled 213 COVID-19 patients who were diagnosed following the criteria of Guidelines for the Diagnosis and Treatment of COVID-19 Pneumonia published by the National Health Commission of the People's Republic of China (7th edition, in Chinese) 12 and who were admitted to Union Hospital of Tongji Medical College in Wuhan, China, from 24 January to 24 February 2020. Clinical information, laboratory data, hospitalized days, disease progression and clinical outcome at admission (the acute period) were collected from electronic medical records. The chest CT imaging on admission and follow-up period were collected from picture archiving and communication systems (PACS). The body weight and height were measured at admission by trained nurses according to standard protocols. 2 BMI (kg/m 2 ) was calculated by dividing weight (kg) by height (m) squared. Patients were classified according to their BMI into three groups with Chinese-specific cut-offs: normal weight (from 18.5 to <24 kg/m 2 ), overweight (from 24 to <28 kg/m 2 ) and obesity (≥28 kg/m 2 ). 13 The detailed inclusion and exclusion processes were shown in Figure 1 . the presence of any of the following conditions: (a) respiratory failure requiring mechanical ventilation; (b) shock; and (c) other organ failures with the need for ICU treatment. The discharge criteria met all the following conditions: no fever for at least 3 days, marked improvement in respiratory symptoms, obvious absorption and recovery of acute exudative lesions on lung imaging, and two consecutive negative test results for SARS-CoV-2 (sputum or nasopharynx swab samples were collected at least 24 h apart). All the patients were informed to perform the follow-up CT examinations at 3-6 months upon discharge.

The chest CT scans were acquired with patients in the supine position and the range of the chest CT scans covering from the upper level of the thoracic inlet to the inferior level of the costophrenic angle. All the patients were trained on basic breath-holding to minimize the respiratory movement artefacts and the scans were performed at the end inspiration period. Patients were screened using either of the two multidetector CT scanners (Philips Ingenuity Core128, Philips Medical Systems, Best; or SOMATOM Definition AS, Siemens Healthineers).

The scan parameters were the standard clinical scan parameters. The raw data were reconstructed in transverse orientation with either a hybrid iterative reconstruction technique (iDose level 5, Philips

Medical Systems) or a pulmonary B70F kernel and a mediastinal B30f kernel (Siemens Healthineers), then the reconstructed images were transmitted to the workstation and PACS. The abdominal fat deposition was measured at the thoracoabdominal level of the first slice where lung bases were no more visible, which was a valid method to measure abdominal fat in humans. 11 To quantify the abdominal adipose tissue, all the CT data of the mediastinal window were transferred to a commercial workstation (IntelliSpace Discovery, version 3.0, Philips Healthcare), and then the method of measuring VAT, total adipose tissue (TAT) and subcutaneous adipose tissue (SAT) was as the previous study described. 11 The area of VAT, TAT and SAT was expressed in cm 2 . The measurements were assessed three times by two radiologists (Xiang Ma and Xiaoting Lu) and a mean of the values was recorded to reduce bias.

Qualitative data were expressed as frequency rates and percentages (%), and quantitative data were expressed as medians (interquartile ranges [IQR]). Qualitative data was compared among the three groups using the Chi-square test or Fisher's exact test, and quantitative data was analysed using the Kruskal-Wallis test. The univariate and multivariate logistic regressions were performed to identify the independent predictive factors of severe or critical cases involving the clinical, AI parameters and fat deposition assessment on acute period and total lung lesions volume absorption rate <99.0% C-indexes of predicted probability for the predictive models were evaluated by ROC curve estimation. All statistical analyses were performed using IBM SPSS Statistics Software (version 24; IBM).

A two-sided p-value <0.05 was considered statistically significant.

A total of 213 patients were enrolled in this study, of whom 47.4% were of normal weight, 37.6% overweight and 15.0% obesity. The median age among the three groups was similar (57.0-58.0 years). Men accounted for a higher percentage in the overweight group (51.3%) and obese group (65.6%) than in the normal-weight group (43.6%). The clinical signs and symptoms including fever, cough, sputum, dyspnoea, vomiting, diarrhoea, weakness and muscular soreness showed no difference among the three groups (all p > 0.05). Comorbidities (detailed in Table 1 ) including hypertension, diabetes mellitus, cardiovascular disease and cerebrovascular disease were slightly higher in the obese group than the two other groups.

The level of alanine aminotransferase, blood uric acid, total cholesterol, triglyceride and low-density lipoprotein (LDL)-cholesterol were higher in obese patients and overweight patients than in normal-weight patients (all p < 0.05), and the high-density lipoprotein (HDL)-cholesterol level was lower in obese patients and overweight patients than in normal-weight patients (p < 0.05). Clinical data were demonstrated in Table 1 for each group.

The obese group endured the longest hospitalization (18.0 days), then the overweight group (16.0 days), and the normal-weight group endured the shortest hospitalized days (14.0 days), with no statistical significance (p = 0.584). 40.6% obese patients and 27.5% overweight patients progressed to severe or critical cases, while the percentage in the normal-weight group was 15.8%; the p-value among the three groups had statistical difference (p = 0.011). In descending order, the percentage of patients demanding mechanical ventilation was 6.3% in the obese group, 2.5% in the overweight group and 2.0% in the normalweight group, respectively, and the percentage of patients requiring ICU treatment was 9.4% in the obese group, 3.8% in the overweight group and 2.0% in the normal-weight group, respectively. The death rates in the three groups were 3.0% in the normal-weight group, 1.3% in the overweight group and 9.4% in the obese group. 

The area of abdominal adipose tissue including VAT, TAT and SAT among the three groups had significant differences (all p < 0.05) at both acute period and 5-month follow-up. The area of abdominal adipose tissue was the largest in the obese group, followed by the overweight group and the least in the normal-weight group. The proportion of increased VAT, TAT and SAT numbers among the three groups had no differences (detailed in Tables 2 and 3 ). 

Defined total lung lesion volume absorption rates <99.0% as endpoint event and univariate associations with the endpoint were assessed for all baseline general clinical characteristics and laboratory results, together with CT-derived abdominal adipose tissue parameters. put patients under double disease burden; therefore, the study to explore the association of obesity and COVID-19 was critical.

The present study found that obese patients showed more severe pneumonia lesions on CT examination at both admission and 5month follow-up. At the acute period, LV, GV, PLV and PGV showed significant differences among the three groups, which was consistent with a previous study. 6 Unexpectedly, the CV and PCV at the acute stage showed no significant difference in this study. On chest CT

imaging, GGO appears as an area of hazy increased lung opacity, with preservation of bronchial and vascular margins; from a pathological point of view, GGO is caused by the partial filling of lung airspaces, lung interstitial thickening (due to fluid, cells, and/or fibrosis), partial collapse of lung alveoli, increased capillary blood volume or a combination of these, the common factor being the partial displacement of airspaces. 18 The GGO is often superimposed with a crazy-paving pattern and can be produced by lung disease that affects both the interstitial and airspace compartments, which was the main imaging feature in COVID-19 patients and can appear in the whole course of the COVID-19 lung lesions. 19 Consolidation on chest CT scans is defined as a homogeneous increase in pulmonary parenchymal attenuation that obscures the margins of vessels and airway walls; in pathology, consolidation refers to an inflammatory exudation or other products of disease that replaces alveolar air, rendering the lung solid. 18 comorbidities, the presence of hypertension, dyslipidaemia, prediabetes and insulin resistance might predispose individuals to increased susceptibility to infection, cardiac dysfunction and impaired immune response. 30 In this study, the presence of obesity-related comorbidities including diabetes mellitus, cardiovascular disease and kidney disease was higher in obese patients than normal-weight patients, which can partly explain the poor prognosis of obese patients. In addition, dyslipidaemia in the present study including higher total cholesterol, higher triglyceride, lower HDL-cholesterol and higher LDL-cholesterol also confirmed the hypothesis. Moreover, the obese patients had more VAT which was also demonstrated in this study. On the one hand, excess fat was associated with complement system overactivation, which was potentially capable of inducing inflammatory sequelae, ultimately leading to a condition described as 'cytokine storm'. On the other hand, the VAT can secrete interleukin-6 (IL-6),

which demonstrated an increased level in SARS-CoV-2 nonsurvivors. 31, 32 Furthermore, the level of angiotensin-converting enzyme 2 expression in adipose tissue may increase the affinity of the organism and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and therefore result in a severe course in obese illness with COVID-19. 33 Interestingly, the increased VAT was strongly associated with an absorption rate <99% on the 5-month follow-up in this study, which further confirmed that an excess of VAT had an adverse impact on the outcome of the COVID-19.

This study performed a clinical-plus-AI model to predict the adverse outcomes of patients and demonstrated this combinational model superior to the model with clinical parameters alone. As the COVID-19 pandemic has put great pressure on global healthcare systems, early risk stratification was helpful for medical staff to triage infected patients and allocate limited medical resources. It was reported that chest CT with AI quantitative analysis system can accurately diagnose COVID-19 and predict pneumonia lesions progression to severe illness in the early phase and, hence, can assist the physicians to determine if the patients will require close monitoring and early intervention/support as needed rapidly. 15, 34 While many clinical and imaging models were performed in previous studies to predict the adverse outcome of the disease, [35] [36] [37] the current study was, to the authors' knowledge, the first that combined clinical variables with AI-based chest CT quantification and VAT parameters for prognostication in obese patients infected with COVID-19.

Some limitations existed in this study. First, as a single-centre study, the sample size was not large, with only 213 inpatients included. However, the incidences of obesity and overweight in this cohort were similar to a previous report on the whole figure over

China, 2 and the sample was therefore considered to represent the patients in the whole region. Further large-sample studies that include races in addition to Chinese will be needed to validate the prediction model in this study. Second, underweight patients were not discussed as we were unable to collect enough patients of this

condition. In addition, other serum risk factors such as D-dimer, IL-6 and troponin were not available in most of the patients in our cohort and thus were not included in our risk prediction models.

In conclusion, this study demonstrated obesity was associated with severe pneumonia lesions on CT and adverse clinical outcome on the acute period. In the 5-month follow-up of CT examinations, the residual lung lesions were more severe, and the lesion absorption rates were lower in obese patients. Meanwhile, this present study constructed a clinical-plus-AI prediction model for obesity so that medical staff can identify and manage potential severe and critical patients rapidly.

COVID-19 Weekly Epidemiological Update

Obesity and COVID-19 severity in a designated hospital in Shenzhen

How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre

Obesity is a potential risk factor contributing to clinical manifestations of COVID-19

Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic

Obese COVID-19 patients show more severe pneumonia lesions on CT chest imaging

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORO-NADO study

Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease

Computed tomography highlights increased visceral adiposity associated with critical illness in COVID-19

Visceral fat is associated to the severity of COVID-19

Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19

New Coronavirus Pneumonia Prevention and Control Program

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

A predictive model for disease progression in non-severe illness patients with coronavirus disease

CT quantification of pneumonia lesions in early days predicts progression to severe illness in a cohort of COVID-19 patients

Glycemic status affects the severity of coronavirus disease 2019 in patients with diabetes mellitus: an observational study of CT radiological manifestations using an artificial intelligence algorithm

Prevalence of Obesity Among Adults, BMI ≥ 30, Age-Standardized Estimates by WHO Region

Fleischner Society: glossary of terms for thoracic imaging

Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia

CT manifestations of coronavirus disease-2019: a retrospective analysis of 73 cases by disease severity

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study

High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation

Severe obesity as an independent risk factor for COVID-19 mortality in hospitalized patients younger than 50

Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality

Global pandemics interconnected -obesity, impaired metabolic health and COVID-19

Body mass index and risk for COVID-19-related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death-United States

Association of body mass index with severity and mortality of COVID-19 pneumonia: a two-center, retrospective cohort study from Wuhan

6-Month consequences of COVID-19 in patients discharged from hospital: a cohort study

Altered respiratory physiology in obesity

Obesity and impaired metabolic health in patients with COVID-19

Obesity and SARS-CoV-2: a population to safeguard

Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine

Interaction of SARS-CoV-2 and other coronavirus with ACE (angiotensin-converting enzyme)-2 as their main receptor

Clinically applicable AI system for accurate diagnosis, quantitative measurements, and prognosis of COVID-19 pneumonia using computed tomography

Well-aerated lung on admitting chest CT to predict adverse outcome in COVID-19 pneumonia

Prediction models for diagnosis and prognosis of Covid-19: systematic review and critical appraisal

Quantitative burden of COVID-19 pneumonia at chest CT predicts adverse outcomes: a post hoc analysis of a prospective international registry

The association of obesity with the progression and outcome of COVID-19: the insight from an artificial-intelligence-based imaging quantitative analysis on computed tomography

The authors thank all the patients and health providers involved in this study. The authors greatly appreciate the assistance of Zhiang in the quantitative evaluation of CT imaging.

All the authors declare no conflict of interests.

The present study was approved by the research ethics committees of Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (number 2020 0026).

Study design, manuscript drafting, data collection and CT evaluation: 

The dataset generated during the current study is available from the corresponding author on reasonable request.

https://orcid.org/0000-0002-5029-353XJiazheng Wang https://orcid.org/0000-0003-1182-442X

The peer review history for this article is available at https://publons. com/publon/10.1002/dmrr.3519.